Grape molasses improved swallowing and appetite and reduced pain and fatigue in chemotherapy. Oral health 19. 01. 2022 Patients with head and neck cancer who used molasses from grapes during chemotherapy and radiotherapy, opened their mouths better and lost less weight than the control group, according to a study. Also, patients had better scores on functionality, emotional and social parameters, fatigue, appetite, and pain during chemotherapy and radiotherapy compared to the control group, which did not drink petimezi. According to the instructions, the patients gargled the grape molasses, twice a day, and then swallowed it, from the beginning of the radiotherapy to the end. They were told not eat anything for the next 15-20 minutes so as not to disrupt the coverage of the mucous membrane in the mouth by the grape molasses. The study evaluated 94 patients who received chemotherapy and radiotherapy for cancer of the head and neck. Nasopharyngeal cancer was the most common, followed by laryngeal and oral cancer and other types of tumors. Mucositis (stomatitis), mouth pain and weight loss were measured weekly. Sari SY et al. Do grapes and black mulberry molasses have an effect on oral mucositis and quality of life in patients with head and neck cancer? Supportive Care in Cancer 2022;30:327-336. Tags: radiotherapy , appetite , fatigue , stomatitis , chemotherapy
Medication-Related Osteonecrosis of the Jaw (MRONJ): From Theory to Practice – Advanced Training Webinar Events, Seminars, & Publications 28. 01. 2026 The Next Step in Managing Patients on Antiresorptive MedicationsOn January 16, 180 dentists attended our first webinar on MRONJ and risk assessment.The response was immediate:“The STEPS and their eval...[Read more]
Osteonecrosis of the Jaw (MRONJ): The 3-Step Safety System for Dentists Events, Seminars, & Publications 25. 06. 2026 How to Treat Patients Receiving Antiresorptive Medications with ConfidenceIn our previous webinars, hundreds of dentists discovered a system that has transformed the way they manage high-risk patients...[Read more]
Advanced protocols for the management of high-risk patients Events, Seminars, & Publications 10. 02. 2026 Οστεονέκρωση Γνάθων (MRONJ): Από τη Θεωρία στην Πράξη - 3ο Webinar ΕξειδίκευσηςWhat Happened in the Previous Webinars?On January 16, 180 dentists attended the first webinar.On February 6, 174 dentists...[Read more]